← Back to Search

Virtual Care Optimization for COPD Management (VC-OPTIONS Trial)

N/A
Waitlist Available
Led By Stephanie Robinson, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
COPD diagnosis
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial will use a multi-component strategy to increase adoption of virtual care services (VC) for COPD management through VA's Annie texting program, with the goal of making VC more accessible and easier to use.

Who is the study for?
This trial is for US Veterans who are users of the Veterans Health Administration (VHA), have been diagnosed with COPD, can communicate in English, and own a text-enabled phone. It's not open to those who've already taken part in research preparing for this intervention.
What is being tested?
The study is testing VC-OPTIONS, an approach designed to increase virtual care use for managing COPD. It involves sending information through VA's Annie texting program to educate patients about virtual services available for their condition.
What are the potential side effects?
Since the intervention focuses on education and communication via text messages rather than medical or drug treatments, there are no direct physical side effects associated with participating in this trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with COPD.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Feasibility
Secondary study objectives
Acceptability
Appropriateness
Awareness of Virtual Care
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: VC-OPTIONSExperimental Treatment1 Intervention
Participants will be enrolled in the Annie texting VC-OPTIONS protocol

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,658 Previous Clinical Trials
3,361,573 Total Patients Enrolled
Stephanie Robinson, PhDPrincipal InvestigatorVA Bedford HealthCare System, Bedford, MA

Media Library

VC-OPTIONS Clinical Trial Eligibility Overview. Trial Name: NCT05986214 — N/A
Chronic Obstructive Pulmonary Disease Research Study Groups: VC-OPTIONS
Chronic Obstructive Pulmonary Disease Clinical Trial 2023: VC-OPTIONS Highlights & Side Effects. Trial Name: NCT05986214 — N/A
VC-OPTIONS 2023 Treatment Timeline for Medical Study. Trial Name: NCT05986214 — N/A
~27 spots leftby Sep 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top